Bipartisan House members sent a letter to the FDA commissioner to complain about the agency's “completely insufficient response” to their bill, which called for hemp-derived CBD to be permitted and regulated as a food additive. 

Reps. Kathleen Rice (D-NY), Morgan Griffith (R-VA), Angie Craig (D-MN), and Dan Crenshaw (R-TX) said the FDA “does not address provisions of our bill drafted specifically to address product safety, and is a completely insufficient response at this moment when cannabidiol (CBD) products are proliferating around the country,” reported Marijuana Moment.

What Happened: In December, the “CBD Product Safety and Standardization Act” was filed and sponsors sought technical assistance from FDA to advise on necessary provisions. The bill aims to help resolve the ongoing regulatory issue hemp stakeholders have asked the FDA to clear up.

What Did The Letter Say?

In the recent letter, lawmakers said that four months after they sent the inquiry, the FDA returned a “one-page” response that was “simply a …

Full story available on Benzinga.com